Streetbeat News

Analyst Ratings

ITW

Wells Fargo analyst Joseph O'Dea downgraded Illinois Tool Works (ITW) from Equal-Weight to Underweight and reduced the price target from $277 to $240.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:08 pm

PLTR

Palantir Technologies, Inc. (NYSE:PLTR) exceeded fourth-quarter revenue forecasts and met bottom-line expectations, marking its fourth consecutive quarter of GAAP profitability. Wedbush analyst Daniel Ives, impressed by Palantir's performance, maintained an Outperform rating and increased the price target from $25 to $30, indicating a 79.43% upside potential. Ives highlighted Palantir's significant commercial success, particularly in AI, noting a 70% growth in commercial business and a 44% increase in commercial customer count in Q4. Despite the volatility in the Government business segment, Ives is optimistic about Palantir's U.S. commercial business, projecting at least 40% growth in 2024 and potential S&P 500 inclusion.

Portfolio Pulse from Shanthi Rexaline

February 06, 2024 | 1:03 pm

TSN

B of A Securities analyst Bryan Spillane upgraded Tyson Foods (NYSE:TSN) from Underperform to Neutral and increased the price target from $47 to $62.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:01 pm

DASH

Recent analyst ratings for DoorDash (NASDAQ:DASH) show a predominantly bullish outlook, with an average 12-month price target of $123.14, indicating a 22.32% increase from the previous target. The ratings reflect updates from analysts at firms like Needham, Roth MKM, Mizuho, BMO Capital, Jefferies, and Deutsche Bank, with actions ranging from maintaining to raising price targets. DoorDash's financial overview reveals a solid revenue growth rate of 27.22% as of September 30, 2023, but challenges in profitability and asset utilization are noted.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 1:00 pm

TER

Teradyne's (NYSE:TER) short interest has increased to 7.74% since the last report, with 4.68 million shares sold short, representing 3.48% of its float. This indicates a bearish market sentiment towards TER, although it has less short interest compared to its peers' average of 6.60%. The article suggests that an increase in short interest does not necessarily predict a near-term price fall.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 1:00 pm

AXSM

Axsome Therapeutics (NASDAQ:AXSM) has received diverse analyst ratings over the last three months, with a notable increase in the average 12-month price target to $131.38 from $90.00, indicating a 45.98% rise. The company, a clinical-stage biopharmaceutical firm focusing on CNS disorders, has shown a significant revenue growth rate of 243.07% as of September 30, 2023. However, it faces challenges with a net margin of -107.62% and below-average ROE and ROA. Analysts from firms like UBS, RBC Capital, Cantor Fitzgerald, Piper Sandler, HC Wainwright & Co., and Citigroup have provided ratings ranging from Buy to Overweight, with price targets up to $180.00.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 1:00 pm

UPS

UBS analyst Thomas Wadewitz upgraded United Parcel Service (UPS) from Neutral to Buy and increased the price target from $160 to $175.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:58 pm

CHGG

COST

LI

PLTR

UBER

Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including Uber, Costco, Chegg, Palantir, Li Auto, Saia, Church & Dwight, Bristol-Myers Squibb, Vertex Pharmaceuticals, and Catalent. These changes reflect the analysts' latest views on these stocks, with some receiving upgrades, downgrades, or adjustments in price targets.

Portfolio Pulse from Avi Kapoor

February 06, 2024 | 12:54 pm

AXSM

UBS analyst Ashwani Verma initiates coverage on Axsome Therapeutics (AXSM) with a Buy rating and a price target of $111.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:50 pm

BHVN

UBS analyst Ashwani Verma initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 12:47 pm